Literature DB >> 6609962

Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.

R I Fox, S Fong, C Tsoukas, J H Vaughan.   

Abstract

Five patients with rheumatoid arthritis (RA), who were treated by lymphocyte depletion by using thoracic duct drainage (TDD), provided an opportunity to characterize the phenotype and function of their recirculating lymphocytes. We found that: a) thoracic duct lymphocytes (TDL) were similar in their proportion of T cells (83% +/- 6 OKT3+), OKT4+ subset (65% +/- 8), and OKT8+ subset (22% +/- 6) to peripheral blood lymphocytes (PBL): b) fewer natural killer-like cells were present in TDL (5% +/- 4 Leu-7+; 2% +/- 2 Leu-11+: 8% +/- 2 OKM -1+) than in PBL (20% +/- 10 Leu-7+: 11% +/- 6 Leu-11+; 18% +/- 5 OKM -1) (p less than 0.01); c) TDL differed from synovial fluid lymphocytes ( SFL ) and synovial membrane lymphocytes ( SML ) in that TDL lacked a high percentage of activated lymphocytes (T cells bearing Ia antigen, OKT10 , and transferrin receptor): d) immature T cells (expressing either OKT6 antigen or reactive with peanut agglutinin) were not found in TDL even late in the course of TDD: and e) in vitro functional studies demonstrated that TDL were similar to PBL in their ability to synthesize immunoglobulin after mitogen stimulation and to generate cytotoxic T lymphocytes capable of lysing autologous EBV-transformed B cells. However, natural killer activity, as measured by lysis of K562 cells was significantly lower in TDL than PBL (p less than 0.05). These results demonstrate that natural killer cells defined by phenotype and function are excluded from thoracic duct lymph and thus have a circulation pattern different from most T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

2.  Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.

Authors:  Teresa A Simon; Johan Askling; Diane Lacaille; Jarrod Franklin; Frederick Wolfe; Allison Covucci; Samy Suissa; Marc C Hochberg
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

Review 3.  Distribution of lymphocyte subsets and natural killer cells in the human body.

Authors:  J Westermann; R Pabst
Journal:  Clin Investig       Date:  1992-07

4.  Thoracic duct drainage in rheumatoid arthritis.

Authors:  J H Vaughan; R I Fox; R J Abresch; C D Tsoukas; J G Curd; D A Carson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

5.  The Identity of Human Tissue-Emigrant CD8+ T Cells.

Authors:  Marcus Buggert; Laura A Vella; Son Nguyen; Vincent H Wu; Zeyu Chen; Takuya Sekine; André Perez-Potti; Colby R Maldini; Sasikanth Manne; Samuel Darko; Amy Ransier; Leticia Kuri-Cervantes; Alberto Sada Japp; Irene Bukh Brody; Martin A Ivarsson; Jean-Baptiste Gorin; Olga Rivera-Ballesteros; Laura Hertwig; Jack P Antel; Matthew E Johnson; Afam Okoye; Louis Picker; Golnaz Vahedi; Ernesto Sparrelid; Sian Llewellyn-Lacey; Emma Gostick; Johan K Sandberg; Niklas Björkström; Amit Bar-Or; Yoav Dori; Ali Naji; David H Canaday; Terri M Laufer; Andrew D Wells; David A Price; Ian Frank; Daniel C Douek; E John Wherry; Maxim G Itkin; Michael R Betts
Journal:  Cell       Date:  2020-12-10       Impact factor: 66.850

6.  Concomitant herpes simplex keratitis and autoimmune-associated ulcerative keratitis in rheumatoid arthritis patients.

Authors:  Masaaki Yoshida; Takehiro Hariya; Shunji Yokokura; Wataru Kobayashi; Ryu Watanabe; Tomonori Ishii; Toru Nakazawa
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.